Related Experiment Videos
Branch retinal vein occlusion after spontaneous obliteration of retinal arterial macroaneurysm
M Battaglia Parodi1, E Bondel, S Saviano
1Eye Clinic, University of Trieste, Italy.
Retina (Philadelphia, Pa.)
|September 8, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Choroidal excavation in choroidal osteoma complicated by choroidal neovascularization.
Eye (London, England)·2017
Optical coherence tomography analysis of evolution of Bruch's membrane features in angioid streaks.
Eye (London, England)·2017
Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2014
Intravitreal bevacizumab for choroidal neovascularisation in serpiginous choroiditis.
The British journal of ophthalmology·2014
Pharmacological approach to diabetic macular edema.
Ophthalmic research·2013
Clinical outcomes of epiretinal membrane surgery in patients with good baseline visual acuity.
Retina (Philadelphia, Pa.)·2026
Serum Ang-1, sFLT-1, and sST2 Profiles Distinguish Anti-VEGF Responders in Diabetic Macular Edema.
Retina (Philadelphia, Pa.)·2026
Structural and Microvascular Alterations in Macular Telangiectasia Type 2: The Diagnostic Value of Vessel Tortuosity.
Retina (Philadelphia, Pa.)·2026
Long-Term Foveal Microvascular Alterations in Children With Hypoxic-Ischemic Encephalopathy: An OCT Angiography Study.
Retina (Philadelphia, Pa.)·2026
Unilateral nonarteritic anterior ischemic optic neuropathy associated with obstructive sleep apnea-hypopnea syndrome: a case report.
Journal of medical case reports·2026
Application of nanozyme-based drug delivery systems in the treatment of ROS-related ophthalmic diseases.
International journal of pharmaceutics: X·2026
Nano formulations of quercetin for ocular delivery.
BioImpacts : BI·2026